| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 25 | 2026 | 409 | 1.850 |
Why?
|
| Cognitive Dysfunction | 17 | 2026 | 235 | 1.800 |
Why?
|
| Cognition Disorders | 18 | 2018 | 237 | 1.450 |
Why?
|
| Aging | 21 | 2026 | 352 | 1.440 |
Why?
|
| Brain | 18 | 2024 | 331 | 1.300 |
Why?
|
| Aged, 80 and over | 46 | 2026 | 1034 | 1.100 |
Why?
|
| Aged | 49 | 2026 | 1860 | 1.030 |
Why?
|
| Female | 66 | 2026 | 3346 | 1.030 |
Why?
|
| Male | 63 | 2024 | 3399 | 0.990 |
Why?
|
| Humans | 76 | 2026 | 5837 | 0.970 |
Why?
|
| Cognition | 17 | 2024 | 337 | 0.940 |
Why?
|
| Dementia | 7 | 2021 | 127 | 0.660 |
Why?
|
| Longitudinal Studies | 18 | 2019 | 363 | 0.560 |
Why?
|
| Cohort Studies | 18 | 2024 | 406 | 0.510 |
Why?
|
| Parkinsonian Disorders | 4 | 2019 | 43 | 0.500 |
Why?
|
| Parkinson Disease | 8 | 2017 | 134 | 0.490 |
Why?
|
| Tourette Syndrome | 3 | 2009 | 4 | 0.460 |
Why?
|
| Neuropsychological Tests | 15 | 2019 | 309 | 0.430 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2023 | 28 | 0.420 |
Why?
|
| Nervous System Diseases | 3 | 2023 | 24 | 0.380 |
Why?
|
| DNA-Binding Proteins | 5 | 2019 | 94 | 0.340 |
Why?
|
| Independent Living | 5 | 2019 | 62 | 0.320 |
Why?
|
| Quality of Life | 3 | 2009 | 108 | 0.320 |
Why?
|
| Huntington Disease | 2 | 2008 | 19 | 0.320 |
Why?
|
| Piperidines | 2 | 2006 | 8 | 0.310 |
Why?
|
| Literacy | 2 | 2021 | 9 | 0.290 |
Why?
|
| Neuropathology | 3 | 2018 | 17 | 0.290 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2023 | 207 | 0.270 |
Why?
|
| Memory, Short-Term | 5 | 2022 | 37 | 0.270 |
Why?
|
| Cognitive Aging | 2 | 2018 | 27 | 0.260 |
Why?
|
| Indans | 1 | 2006 | 4 | 0.250 |
Why?
|
| Chorea | 1 | 2006 | 3 | 0.250 |
Why?
|
| Recovery of Function | 1 | 2006 | 64 | 0.240 |
Why?
|
| Middle Aged | 15 | 2017 | 1775 | 0.240 |
Why?
|
| Neurodegenerative Diseases | 2 | 2018 | 39 | 0.240 |
Why?
|
| Antipsychotic Agents | 1 | 2006 | 12 | 0.240 |
Why?
|
| Disease Progression | 8 | 2019 | 157 | 0.230 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 33 | 0.230 |
Why?
|
| HIV Infections | 2 | 2017 | 135 | 0.230 |
Why?
|
| Motor Activity | 3 | 2015 | 83 | 0.220 |
Why?
|
| Educational Status | 3 | 2021 | 60 | 0.210 |
Why?
|
| Arteriolosclerosis | 1 | 2023 | 14 | 0.200 |
Why?
|
| Memory, Episodic | 3 | 2019 | 26 | 0.200 |
Why?
|
| Plaque, Amyloid | 2 | 2015 | 29 | 0.200 |
Why?
|
| Disability Evaluation | 4 | 2019 | 60 | 0.200 |
Why?
|
| Atherosclerosis | 1 | 2023 | 10 | 0.190 |
Why?
|
| Lewy Body Disease | 3 | 2018 | 29 | 0.190 |
Why?
|
| Hypertension | 2 | 2022 | 35 | 0.190 |
Why?
|
| Flavonols | 1 | 2022 | 5 | 0.190 |
Why?
|
| Crime Victims | 1 | 2022 | 9 | 0.180 |
Why?
|
| Autopsy | 5 | 2023 | 67 | 0.180 |
Why?
|
| Comorbidity | 5 | 2018 | 98 | 0.180 |
Why?
|
| Risk Factors | 10 | 2017 | 499 | 0.180 |
Why?
|
| Perception | 2 | 2019 | 30 | 0.180 |
Why?
|
| Cross-Sectional Studies | 8 | 2022 | 203 | 0.170 |
Why?
|
| Stroke | 2 | 2019 | 71 | 0.170 |
Why?
|
| Hippocampus | 3 | 2019 | 61 | 0.170 |
Why?
|
| Disabled Persons | 2 | 2012 | 24 | 0.170 |
Why?
|
| Severity of Illness Index | 7 | 2018 | 187 | 0.170 |
Why?
|
| Music | 1 | 2021 | 8 | 0.170 |
Why?
|
| Death | 1 | 2021 | 11 | 0.170 |
Why?
|
| Adult | 11 | 2010 | 1670 | 0.170 |
Why?
|
| Sleep Wake Disorders | 2 | 2012 | 30 | 0.160 |
Why?
|
| Brain Infarction | 2 | 2018 | 23 | 0.160 |
Why?
|
| Loneliness | 2 | 2017 | 22 | 0.150 |
Why?
|
| Neurocognitive Disorders | 1 | 2019 | 9 | 0.150 |
Why?
|
| Memory Disorders | 2 | 2018 | 48 | 0.150 |
Why?
|
| Accelerometry | 1 | 2019 | 14 | 0.150 |
Why?
|
| Video Recording | 1 | 1999 | 5 | 0.150 |
Why?
|
| Wearable Electronic Devices | 1 | 2019 | 13 | 0.150 |
Why?
|
| Apolipoprotein E4 | 3 | 2015 | 92 | 0.140 |
Why?
|
| Hypoventilation | 2 | 2010 | 27 | 0.140 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2019 | 10 | 0.140 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 4 | 0.140 |
Why?
|
| Diet, Mediterranean | 1 | 2019 | 19 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 21 | 0.140 |
Why?
|
| Range of Motion, Articular | 1 | 2019 | 136 | 0.140 |
Why?
|
| Cholecystokinin | 2 | 2011 | 5 | 0.140 |
Why?
|
| Hallucinations | 2 | 2011 | 9 | 0.140 |
Why?
|
| Gait | 1 | 2019 | 93 | 0.140 |
Why?
|
| Prospective Studies | 5 | 2022 | 411 | 0.140 |
Why?
|
| Osteoporosis | 1 | 2018 | 33 | 0.140 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 8 | 0.140 |
Why?
|
| Temporal Lobe | 1 | 2018 | 17 | 0.140 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2018 | 7 | 0.140 |
Why?
|
| Learning | 1 | 2018 | 23 | 0.130 |
Why?
|
| Knee Joint | 1 | 2019 | 118 | 0.130 |
Why?
|
| Spinal Cord | 1 | 2017 | 23 | 0.130 |
Why?
|
| Urinary Incontinence | 1 | 2017 | 7 | 0.130 |
Why?
|
| Postmortem Changes | 1 | 2016 | 9 | 0.120 |
Why?
|
| Biostatistics | 1 | 2016 | 3 | 0.120 |
Why?
|
| Residence Characteristics | 2 | 2015 | 43 | 0.120 |
Why?
|
| Models, Statistical | 1 | 2016 | 36 | 0.120 |
Why?
|
| White Matter | 1 | 2016 | 24 | 0.120 |
Why?
|
| Munc18 Proteins | 1 | 2015 | 2 | 0.120 |
Why?
|
| GABAergic Neurons | 1 | 2015 | 2 | 0.120 |
Why?
|
| Motor Disorders | 1 | 2015 | 4 | 0.110 |
Why?
|
| Adolescent | 5 | 2010 | 488 | 0.110 |
Why?
|
| Organ Size | 1 | 2015 | 16 | 0.110 |
Why?
|
| Muscle Strength | 2 | 2019 | 23 | 0.110 |
Why?
|
| Antiporters | 1 | 2015 | 4 | 0.110 |
Why?
|
| HLA-DRB5 Chains | 1 | 2015 | 4 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 6 | 0.110 |
Why?
|
| Cerebral Infarction | 2 | 2015 | 29 | 0.110 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2015 | 6 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 9 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 21 | 0.110 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 30 | 0.110 |
Why?
|
| Membrane Transport Proteins | 1 | 2015 | 29 | 0.110 |
Why?
|
| Interpersonal Relations | 1 | 2014 | 26 | 0.110 |
Why?
|
| Lewy Bodies | 4 | 2019 | 56 | 0.110 |
Why?
|
| DNA Methylation | 1 | 2015 | 72 | 0.110 |
Why?
|
| Activities of Daily Living | 2 | 2012 | 75 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2011 | 72 | 0.100 |
Why?
|
| Child | 4 | 2010 | 339 | 0.100 |
Why?
|
| Incidence | 4 | 2018 | 165 | 0.100 |
Why?
|
| Cytomegalovirus Infections | 1 | 2013 | 11 | 0.100 |
Why?
|
| Supranuclear Palsy, Progressive | 2 | 2006 | 3 | 0.100 |
Why?
|
| Neurologic Examination | 2 | 2006 | 17 | 0.100 |
Why?
|
| United States | 5 | 2017 | 502 | 0.100 |
Why?
|
| Genetic Association Studies | 4 | 2015 | 32 | 0.100 |
Why?
|
| Vision Disorders | 1 | 2012 | 3 | 0.100 |
Why?
|
| Anxiety Disorders | 1 | 2012 | 35 | 0.090 |
Why?
|
| Age Factors | 4 | 2015 | 181 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2009 | 174 | 0.090 |
Why?
|
| Geriatric Assessment | 3 | 2017 | 59 | 0.090 |
Why?
|
| Abnormalities, Multiple | 2 | 2010 | 6 | 0.090 |
Why?
|
| Autonomic Nervous System Diseases | 2 | 2010 | 17 | 0.090 |
Why?
|
| Homeodomain Proteins | 2 | 2010 | 38 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2010 | 61 | 0.090 |
Why?
|
| Receptors, Complement 3b | 1 | 2011 | 8 | 0.080 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 41 | 0.080 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 284 | 0.080 |
Why?
|
| Nerve Degeneration | 1 | 2010 | 16 | 0.080 |
Why?
|
| Risk | 3 | 2015 | 60 | 0.080 |
Why?
|
| Sleep | 2 | 2012 | 88 | 0.080 |
Why?
|
| Time Factors | 4 | 2015 | 374 | 0.080 |
Why?
|
| Substantia Innominata | 1 | 2009 | 3 | 0.080 |
Why?
|
| Amnesia | 1 | 2009 | 9 | 0.080 |
Why?
|
| Chicago | 4 | 2017 | 239 | 0.080 |
Why?
|
| Lung | 1 | 2009 | 31 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2009 | 12 | 0.080 |
Why?
|
| Kidney | 1 | 2009 | 35 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 333 | 0.070 |
Why?
|
| Sex Characteristics | 2 | 2022 | 36 | 0.070 |
Why?
|
| Prognosis | 2 | 2019 | 138 | 0.070 |
Why?
|
| Genotype | 3 | 2015 | 114 | 0.070 |
Why?
|
| Death, Sudden | 1 | 2008 | 4 | 0.070 |
Why?
|
| Circadian Rhythm | 1 | 2008 | 78 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2006 | 601 | 0.070 |
Why?
|
| Sclerosis | 2 | 2019 | 26 | 0.060 |
Why?
|
| Linear Models | 2 | 2018 | 64 | 0.060 |
Why?
|
| Logistic Models | 3 | 2016 | 109 | 0.060 |
Why?
|
| Infant | 2 | 2023 | 184 | 0.060 |
Why?
|
| Placebo Effect | 1 | 2006 | 2 | 0.060 |
Why?
|
| Muscle Rigidity | 1 | 2006 | 2 | 0.060 |
Why?
|
| Dyskinesias | 1 | 2006 | 3 | 0.060 |
Why?
|
| Dioxoles | 1 | 2006 | 4 | 0.060 |
Why?
|
| Receptors, AMPA | 1 | 2006 | 6 | 0.060 |
Why?
|
| Child Behavior Disorders | 1 | 2006 | 8 | 0.060 |
Why?
|
| Nootropic Agents | 1 | 2006 | 7 | 0.060 |
Why?
|
| Alleles | 3 | 2015 | 89 | 0.060 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2026 | 3 | 0.060 |
Why?
|
| Motor Skills | 1 | 2006 | 8 | 0.060 |
Why?
|
| Proteomics | 1 | 2026 | 10 | 0.060 |
Why?
|
| Illinois | 2 | 2017 | 52 | 0.060 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2006 | 28 | 0.060 |
Why?
|
| Walking | 2 | 2022 | 53 | 0.060 |
Why?
|
| Awareness | 1 | 2006 | 13 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2006 | 29 | 0.060 |
Why?
|
| Movement Disorders | 1 | 2005 | 11 | 0.060 |
Why?
|
| West Nile Fever | 1 | 2005 | 1 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 71 | 0.060 |
Why?
|
| Fragile X Syndrome | 1 | 2006 | 124 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2011 | 123 | 0.050 |
Why?
|
| Receptors, Cholecystokinin | 1 | 2004 | 2 | 0.050 |
Why?
|
| Neurofibrillary Tangles | 2 | 2017 | 33 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 26 | 0.050 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2004 | 1 | 0.050 |
Why?
|
| Mental Status Schedule | 2 | 2018 | 32 | 0.050 |
Why?
|
| Fibromyalgia | 1 | 2004 | 5 | 0.050 |
Why?
|
| Occupational Diseases | 2 | 1995 | 2 | 0.050 |
Why?
|
| Spinal Stenosis | 1 | 2004 | 9 | 0.050 |
Why?
|
| Spinal Cord Diseases | 1 | 2004 | 8 | 0.050 |
Why?
|
| Syndrome | 3 | 2010 | 30 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2009 | 64 | 0.050 |
Why?
|
| Statistics as Topic | 2 | 2017 | 22 | 0.050 |
Why?
|
| Healthy Lifestyle | 1 | 2024 | 21 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2011 | 57 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2018 | 78 | 0.050 |
Why?
|
| Low Back Pain | 2 | 1995 | 35 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 26 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 5 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 5 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 16 | 0.050 |
Why?
|
| Fraud | 1 | 2022 | 6 | 0.050 |
Why?
|
| Physical Therapy Modalities | 1 | 2022 | 19 | 0.050 |
Why?
|
| Executive Function | 1 | 2022 | 31 | 0.050 |
Why?
|
| Self Report | 1 | 2022 | 53 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 72 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2022 | 48 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 2 | 2016 | 25 | 0.040 |
Why?
|
| Hypoxia, Brain | 1 | 2001 | 1 | 0.040 |
Why?
|
| Myoclonus | 1 | 2001 | 1 | 0.040 |
Why?
|
| Estrogens | 1 | 2001 | 3 | 0.040 |
Why?
|
| Mathematics | 1 | 2021 | 25 | 0.040 |
Why?
|
| Brazil | 1 | 2021 | 10 | 0.040 |
Why?
|
| Writing | 1 | 2021 | 9 | 0.040 |
Why?
|
| Reading | 1 | 2021 | 9 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2021 | 44 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2011 | 136 | 0.040 |
Why?
|
| Pergolide | 1 | 2000 | 1 | 0.040 |
Why?
|
| Thiazoles | 1 | 2000 | 2 | 0.040 |
Why?
|
| Hypotension, Orthostatic | 1 | 2000 | 4 | 0.040 |
Why?
|
| Dopamine Agonists | 1 | 2000 | 9 | 0.040 |
Why?
|
| Indoles | 1 | 2000 | 11 | 0.040 |
Why?
|
| Family | 1 | 2021 | 26 | 0.040 |
Why?
|
| Microcirculation | 2 | 2011 | 13 | 0.040 |
Why?
|
| Sex Distribution | 2 | 2012 | 16 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2015 | 189 | 0.040 |
Why?
|
| Fitness Trackers | 1 | 2019 | 5 | 0.040 |
Why?
|
| Adoption | 1 | 1979 | 1 | 0.040 |
Why?
|
| Fertility | 1 | 1979 | 4 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2016 | 54 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2021 | 584 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 100 | 0.040 |
Why?
|
| Exercise | 1 | 2019 | 96 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 38 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2011 | 21 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2018 | 112 | 0.030 |
Why?
|
| Community Health Planning | 1 | 2018 | 5 | 0.030 |
Why?
|
| Memory | 1 | 2018 | 61 | 0.030 |
Why?
|
| Dementia, Vascular | 1 | 2018 | 7 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 141 | 0.030 |
Why?
|
| Young Adult | 2 | 2010 | 421 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2009 | 46 | 0.030 |
Why?
|
| Movement | 2 | 1995 | 25 | 0.030 |
Why?
|
| Obstetric Labor, Premature | 1 | 1996 | 2 | 0.030 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 1996 | 2 | 0.030 |
Why?
|
| Twins | 1 | 1996 | 5 | 0.030 |
Why?
|
| Animals | 2 | 2015 | 1349 | 0.030 |
Why?
|
| Intensive Care, Neonatal | 1 | 1996 | 6 | 0.030 |
Why?
|
| Hospital Costs | 1 | 1996 | 8 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2016 | 9 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 53 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2016 | 111 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 10 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 48 | 0.030 |
Why?
|
| Heterozygote | 1 | 2015 | 59 | 0.030 |
Why?
|
| Empathy | 1 | 2014 | 8 | 0.030 |
Why?
|
| Life Change Events | 1 | 2014 | 12 | 0.030 |
Why?
|
| Mental Recall | 1 | 2014 | 14 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 21 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2014 | 58 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 35 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2009 | 60 | 0.030 |
Why?
|
| Depression | 1 | 2014 | 113 | 0.030 |
Why?
|
| Reference Values | 2 | 2006 | 45 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 125 | 0.020 |
Why?
|
| Neuroticism | 1 | 2012 | 6 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 40 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2012 | 41 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 1993 | 77 | 0.020 |
Why?
|
| Actigraphy | 1 | 2012 | 12 | 0.020 |
Why?
|
| Rest | 1 | 2012 | 15 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2010 | 7 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2009 | 8 | 0.020 |
Why?
|
| Child Development | 1 | 2010 | 24 | 0.020 |
Why?
|
| Psychometrics | 1 | 2010 | 52 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2009 | 37 | 0.020 |
Why?
|
| Neocortex | 1 | 2009 | 5 | 0.020 |
Why?
|
| Atrophy | 1 | 2009 | 15 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2009 | 10 | 0.020 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2009 | 6 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 28 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 9 | 0.020 |
Why?
|
| Polysomnography | 1 | 2008 | 21 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2008 | 4 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2008 | 31 | 0.020 |
Why?
|
| Mutation | 1 | 2008 | 101 | 0.020 |
Why?
|
| Pregnancy | 2 | 1996 | 103 | 0.020 |
Why?
|
| Long-Term Potentiation | 1 | 2006 | 4 | 0.020 |
Why?
|
| Drug Eruptions | 1 | 2006 | 5 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2006 | 8 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2006 | 8 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2006 | 10 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2006 | 13 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2006 | 5 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 110 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2006 | 15 | 0.020 |
Why?
|
| Speech | 1 | 2005 | 2 | 0.010 |
Why?
|
| Spain | 1 | 2005 | 4 | 0.010 |
Why?
|
| Cross-Cultural Comparison | 1 | 2005 | 12 | 0.010 |
Why?
|
| Videotape Recording | 1 | 2005 | 4 | 0.010 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2005 | 3 | 0.010 |
Why?
|
| Anisotropy | 1 | 2005 | 18 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2005 | 27 | 0.010 |
Why?
|
| Dopamine Agents | 1 | 2004 | 3 | 0.010 |
Why?
|
| Contrast Media | 1 | 2004 | 16 | 0.010 |
Why?
|
| Cervical Vertebrae | 1 | 2004 | 44 | 0.010 |
Why?
|
| Biomechanical Phenomena | 2 | 1995 | 156 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 150 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2001 | 13 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2001 | 15 | 0.010 |
Why?
|
| Drug Implants | 1 | 2001 | 2 | 0.010 |
Why?
|
| Estradiol | 1 | 2001 | 12 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2001 | 14 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2001 | 23 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2001 | 51 | 0.010 |
Why?
|
| Benzothiazoles | 1 | 2000 | 2 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 36 | 0.010 |
Why?
|
| Acute Disease | 1 | 2000 | 47 | 0.010 |
Why?
|
| Rats | 1 | 2001 | 282 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2001 | 26 | 0.010 |
Why?
|
| Infertility, Female | 1 | 1979 | 2 | 0.010 |
Why?
|
| Infertility, Male | 1 | 1979 | 2 | 0.010 |
Why?
|
| Birth Weight | 1 | 1996 | 10 | 0.010 |
Why?
|
| Morbidity | 1 | 1996 | 12 | 0.010 |
Why?
|
| Health Services Research | 1 | 1996 | 8 | 0.010 |
Why?
|
| Gestational Age | 1 | 1996 | 17 | 0.010 |
Why?
|
| Length of Stay | 1 | 1996 | 45 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1996 | 153 | 0.010 |
Why?
|
| Cumulative Trauma Disorders | 1 | 1995 | 1 | 0.010 |
Why?
|
| Lifting | 1 | 1995 | 1 | 0.010 |
Why?
|
| Posture | 1 | 1995 | 13 | 0.010 |
Why?
|
| Spine | 1 | 1995 | 14 | 0.010 |
Why?
|
| Weight-Bearing | 1 | 1993 | 43 | 0.010 |
Why?
|